imatinib mesylate has been researched along with Colonic Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akioka, T; Hanafusa, T; Hara, S; Nakayama, S; Oka, S; Tsuji, M; Yamano, T; Yokote, T | 1 |
| Asada, N; Asakura, H; Koseki, M; Matsue, K; Takeuchi, M; Uryu, H | 1 |
2 other study(ies) available for imatinib mesylate and Colonic Diseases
| Article | Year |
|---|---|
[Intestinal bleeding during the treatment of chronic myeloid leukemia with imatinib mesylate].
Topics: Adult; Antineoplastic Agents; Benzamides; Colonic Diseases; Female; Gastrointestinal Hemorrhage; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines | 2005 |
Successful combined use of tranexamic acid and unfractionated heparin for life-threatening bleeding associated with intravascular coagulation in a patient with chronic myelogenous leukemia in blast crisis.
Topics: Acute Disease; Adult; alpha-2-Antiplasmin; Antifibrinolytic Agents; Antineoplastic Agents; Antithrombin III; Benzamides; Blast Crisis; Blood Transfusion; Bone Marrow Transplantation; Colon; Colonic Diseases; Disseminated Intravascular Coagulation; Fibrinolysin; Gastrointestinal Hemorrhage; Genes, abl; Heparin; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Peptide Hydrolases; Piperazines; Pyrimidines; Shock; Tranexamic Acid; Transplantation, Homologous | 2007 |